| NCT07023731 | A Study to Evaluate ARV-806 in Adults With Advanced Cancer That Has the KRAS G12D Mutation | RECRUITING | PHASE1, PHASE2 | 2025-05-29 | 2029-04-02 | 2027-11-30 |
| NCT06393738 | A Study of ARV-393 in Relapsed/Refractory Non-Hodgkin Lymphoma. | RECRUITING | PHASE1 | 2024-09-05 | 2025-12 | 2025-12 |
| NCT05549505 | A Trial Using ARV-471 or Anastrozole in Post-Menopausal Women With Breast Cancer Prior to Surgery | COMPLETED | PHASE2 | 2023-02-15 | 2024-07-25 | 2024-07-13 |
| NCT05501769 | ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer | COMPLETED | PHASE1 | 2022-09-08 | 2025-08-25 | 2024-07-03 |
| NCT05177042 | Trial of ARV-110 and Abiraterone in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC) | COMPLETED | PHASE1 | 2022-02-01 | 2025-04-10 | 2024-07-02 |
| NCT04072952 | A Phase 1/2 Trial of ARV-471 Alone and in Combination With Palbociclib (IBRANCE®) in Patients With ER+/HER2- Locally Advanced or Metastatic Breast Cancer | ACTIVE_NOT_RECRUITING | PHASE1, PHASE2 | 2019-08-05 | 2025-11-30 | 2024-09-13 |
| NCT03888612 | Trial of ARV-110 in Patients With Metastatic Castration Resistant Prostate Cancer | COMPLETED | PHASE1, PHASE2 | 2019-03-01 | 2025-01-27 | 2024-04-29 |